Turnstone Biologics Ownership | Who Owns Turnstone Biologics?

Turnstone Biologics Ownership Summary

Turnstone Biologics is owned by 48.17% institutional investors, 3.83% insiders, and 48.00% retail investors.

TSBX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Turnstone Biologics	48.17%	3.83%	48.00%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	28	16.67%	11,096,493	-3.03%	48	1.95%	13	85.71%	6	-40.00%
Sep 30, 2024	24	-45.45%	11,443,046	-9.91%	49	1.63%	7	-73.08%	10	-16.67%
Jun 30, 2024	44	10.00%	12,701,707	-4.85%	55	1.64%	26	8.33%	12	50.00%
Mar 31, 2024	40	11.11%	13,349,616	2.53%	58	0.46%	24	50.00%	8	-11.11%
Dec 31, 2023	36	2.86%	13,020,403	6.69%	112	2.29%	16	-54.29%	9	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 25, 2023	Versant Ventures V, LLC	-	Buy	$2.37M
Jul 25, 2023	Versant Ventures V, LLC	-	Buy	$180.34K
Jul 25, 2023	Versant Ventures V, LLC	-	Buy	$78.90K
Jul 25, 2023	Versant Ventures V, LLC	-	Buy	$71.27K
Jul 20, 2023	ORBIMED ADVISORS LLC		Buy	$5.00M

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	5	-

TSBX Ownership FAQ

Who Owns Turnstone Biologics?

Turnstone Biologics shareholders are primarily institutional investors at 48.17%, followed by 3.83% insiders and 48.00% retail investors. The average institutional ownership in Turnstone Biologics's industry, Biotech Stocks , is 68.48%, which Turnstone Biologics falls below.

Does Blackrock own Turnstone Biologics?

BlackRock is not among the top 10 institutional shareholders of Turnstone Biologics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools